课题基金 / 基金详情

molecular biological characteristics of carcinoma of the papilla of Vater

molecular biological characteristics of carcinoma of the papilla of Vater
Vater乳头癌的分子生物学特征
批准号:
08671413
负责人:
KIMURA Wataru
金额:
$1.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998

项目摘要

项目成果

KIMURA Wataru的其他基金

相似基金

相关文献

中文摘要
翻译
目标。本研究的目的是对胆汁进行分子生物学研究,以鉴别诊断胆道良恶性病变的肿瘤性和非肿瘤性病变。作为这一目的的基础研究,我们对Vater乳头癌的分子生物学特性进行了研究。方法检测乳头状癌组织中P53、p21/Waf1的表达及K-ras密码子12突变情况。本文对37例Vater乳头癌进行了研究。肉眼可见溃疡性癌15例,非溃疡性癌22例。组织学类型:肠型9例,胰胆管型27例,未分化1例。福尔马林固定的石蜡包埋切片用免疫组织化学方法检测p53和p21的表达。采用聚合酶链式反应-限制性片段长度多态性两步法检测K-ras基因第12密码子突变,并进行直接测序。37例中有17例(46%)P53过度表达,溃疡型高于非溃疡型(67%vs.32%,p<0.05)。P21/WAFI蛋白表达阳性率为41%(15/37),与P53蛋白表达无相关性。K-ras基因第12密码子突变在37例中有14例(38%),肠型明显高于胆胰型(66%vs.30%,p<0.05)。在直接测序中,突变主要为GGT到GAT(9/14)和GGT到GTT(4/14)。突变类型与组织学类型无关。在Vater乳头状癌中,P53的过表达可能在肿瘤溃烂中起一定作用。P21/waft的表达是通过不依赖于p53的途径诱导的。肠型和胆胰型癌可能通过不同的机制发生,K-ras基因突变主要与肠型有关。
英文摘要
Objectives. The aim of this study is to perform molecular biological investigation of the bile for differential diagnosis of tumorous and non-tumorous lesions, and of benign and malignant lesions of the biliary tract. As the basic study of this aim, we studied on the molecular biological characteristics of carcinoma of the papilla of Vater. p53 and p21/Waf1 expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater were investigated.Methods. Thirty seven' cases of carcinoma of the papilla of Vater were studied. Macroscopically, the carcinoma was ulcerative in 15 cases and non-ulcerative in 22 cases. Histologically, nine were intestinal type, 27 were pancreaticobiliary type, and one was undifferentiated. Formalin-fixed, paraffin-embedded sections were immunohistochemically stained for p53 and p21. K-ras codon 12 mutation was detected with the two-step polymerase chain reaction-restriction fragment length polymorphism method followed by direct sequencing.Results. p53 overexpression was found in 17 of 37 cases (46%) and was more frequent in the ulcerative type than in the non-ulcerative type (67% vs. 32%, p<0.05). p21/Wafi protein expression was found in 15 of 37 cases (41%), and was not correlated with that of p53. K-ras codon 12 mutation was found in 14 of 37 cases (38%), and was more frequently detected in the intestinal type than in the pancreaticobiliary type (66% vs. 30%, p<0.05). On direct sequencing, the mutations were mainly GGT to GAT (9/14) and GGT to GTT (4/14). The type of mutation did not correlate with the histological type.Conclusions. In carcinoma of the papilla of Vater, p53 overexpression may play a role in tumor ulceration. p21/Waft expression is induced via a p53-independent pathway. Carcinomas of the intestinal and pancreaticobiliary types may develop via different mechanisms, and K-ras mutation is mainly associated with the intestinal type.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kimura W: "Problems in the Diagnosis and Treatment of a So-Called Mucin-Producing tumor of the Pancreas" Pancreas. 16(3). 363-369 (1998)
Kimura W:“所谓的产生粘蛋白的胰腺肿瘤的诊断和治疗中的问题” 胰腺。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
木村 理: "膵液K-ras点突然変異は膵癌診断に有用か?" 外科. 59(1). 67-77 (1997)
Osamu Kimura:“胰液 K-ras 的点突变对于诊断胰腺癌有用吗?” 59(1)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 9 条
    Clinicopathological and molecularbiological study of perineural invasion in pancreatic cancer.
    PATHOGENESIS OF PANCREATIC ACINAR CELL DAMAGE AND POSSIBILIT OF INHIBITION : STUDIES WITH EXPERIMENTAL PANCREATITIS IN RATS
    • 批准号:
      05671048
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.28万
    • 财政年份:
      1993
    • 负责人:
      KIMURA Wataru
    • 依托单位:
    国内基金
    海外基金
    软饮食下Igfbp5调控p53/p21通路诱导颞下颌关节退行性变的机制研究
    • 批准号:
      2026JJ60602
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      周典
    • 依托单位:
    LincRNA-p21通过p21及p53通路调控细胞增殖与凋亡参与PAH肺血管重构的分子机制研究
    • 批准号:
      2025A01015
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      李泽荣
    • 依托单位:
    APEX1调控p53/p21信号通路通过缓解软骨细胞衰老延缓创伤性骨关节炎的机制研究
    • 批准号:
      2025JJ80999
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      何春荣
    • 依托单位:
    通过Sp1/HDAC1/p21途径探索结直肠癌细胞增殖的机制研究
    • 批准号:
      2025JJ70237
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      姜小叶
    • 依托单位: